ForWhen Australian perinatal and infant mental health navigation programme: evaluation protocol =============================================================================================== * Jane Kohlhoff * Sophia A Harris * Kenny D Lawson * Valsamma Eapen ## Abstract **Introduction** Many parents and carers experience mental health challenges during pregnancy and early postpartum years, and there are cumulative shortfalls in the identification, follow-up, and treatment of those experiencing perinatal and infant mental health (PIMH) challenges. ForWhen is a new national navigation programme in Australia that aims to improve outcomes for families by supporting parents and carers to access PIMH services that best meet their needs. This paper presents the protocol of an evaluation of the ForWhen programme, to be conducted over the first 3 years of its implementation. The specific objectives of the evaluation include examining the characteristics of navigation service delivery, its implementation and clinical impact, and identifying potential moderators of change. **Methods and analysis** Utilising a mixed-methods design, this evaluation will incorporate three phases that reflect the stages of the programme life-cycle: (1) programme description, (2) implementation evaluation and (3) outcomes evaluation. The evaluation will use a mix of quantitative and qualitative data including deidentified routinely collected service data, participant observations, semistructured interviews, surveys and questionnaires, and a resource audit. **Discussion** Evaluation findings will be used to inform the development of a refined clinical navigation model, identify barriers and facilitators to successful navigation programme implementation, examine the impact of the ForWhen programme on client clinical outcomes and health service utilisation, understand how the programme is/can be best embedded in the evolving service system, and assess the cost-effectiveness and sustainability of a national navigation programme in improving health outcomes for PIMH in Australia. **Ethics and dissemination** This research was approved by South Western Sydney Local Health District Human Research Ethics Committee (2021/ETH11611). This study was registered on the Australian New Zealand Clinical Trials Registry (ACTRN12622001443785). Results will be disseminated at conferences, in scientific journals, and in a final evaluation report. * PERINATOLOGY * Protocols & guidelines * PUBLIC HEALTH * MENTAL HEALTH ### STRENGTHS AND LIMITATIONS OF THIS STUDY * A major strength of this evaluation is the multimethod, multi-informant approach to data collection. * Another study strength is the implementation evaluation, including an economic analysis, which will inform wider dissemination and scaling. * A study weakness is the lack of a randomised controlled study design to test clinical outcomes. ## Introduction Mental health difficulties occur commonly during pregnancy and the first year postpartum1 2 and are associated with a range of short-term and long-term negative impacts for parents and carers, their families, and children.3 4 Addressing parent and carer mental health needs during the perinatal period is, therefore, of vital importance to protect both adult and infant mental health and well-being over the life course. Recent decades have seen increasing focus given to perinatal and infant mental health (PIMH),5 with a range of government initiatives aimed at implementing universal psychosocial screening into routine antenatal and postnatal healthcare and improving treatment for PIMH, such as the National Perinatal Depression Initiative in Australia.6 Despite increased awareness of, and screening for, PIMH issues, many expectant and new parents/carers are not screened for mental health during perinatal care or do not receive treatment for their distress. A systematic review of international English-language studies by Cox *et al*7 found cumulative shortfalls in recognition, initiation and adequacy of PIMH treatment, and treatment outcomes for women with antenatal or postnatal depression—which the authors termed the ‘perinatal depression treatment cascade’ (p. 1190). Australia-based research has shown screening and treatment rates for PIMH issues to be particularly low for those from non-English-speaking backgrounds,8 those in the private healthcare system,9 and for fathers or non-birth partners.10 While Australian women have high uptake of primary health services during the perinatal period, uptake of specialist mental health services is low. In an Australian study, for example, Schmied *et al* showed that of a sample of women identified to be at moderate to high risk of PIMH, only one-fourth had accessed mental health services by 12 months post partum, and this was predominantly via telephone helplines.11 Research from Australia and abroad has identified a number of patient, provider and system-level barriers, which help explain the gap between screening and treatment rates for PIMH including a lack of appropriate services, stigma and difficulty navigating fragmented PIMH service landscapes.12–14 ### PIMH navigation services as a potential solution Navigation models have been proposed as a cost-effective way to improve access to mental healthcare services and support.15 ‘Navigation’ is defined as a partnership between a patient and a navigator whose role is to guide patients through the complexities of the healthcare system, facilitate timely access to assessment and treatment, and foster patient self-management through education, capacity building and support.16 17 A number of US-based navigation programmes addressing PIMH have demonstrated positive outcomes including a reduction in maternal depression,18 19 higher rates of postpartum visit attendance and depression screening,20 and enhanced utilisation of mental health services.21 However, current evidence regarding the effectiveness of navigation for improving PIMH is sparse, with studies having adopted varied designs and outcome measures. There is also limited information available on navigation activities and services, navigator core competencies or the ways in which various implementation components and contexts impact participant outcomes. Further research evaluating the efficacy and feasibility of navigation services for PIMH will be invaluable for understanding their potential in improving early intervention for parents and families, and for informing sustainable and effective programme design in future. ### ForWhen: a national navigation programme for PIMH In 2021, the Australian government announced that it would provide 3 years of funding to establish and deliver a new national navigation programme for parents and carers experiencing mental health concerns during pregnancy and the first year after birth. Known as ForWhen, the programme is led by Karitane ([www.karitane.com.au](http://www.karitane.com.au)) and delivered around the country by a consortium of partners from the Australian Association of Parenting and Child Health (AAPCH; [www.aapch.com.au](http://www.aapch.com.au)), Parenting Research Centre (PRC; [www.parentingrc.org.au](http://www.parentingrc.org.au)) and the University of New South Wales (UNSW; [www.unsw.edu.au](http://www.unsw.edu.au)). ForWhen proposes to address current PIMH treatment access shortfalls by providing ‘a national comprehensive stepped continuum of care for parents experiencing moderate to severe PIMH concerns, supporting these families to navigate the complex and fragmented PIMH service landscape’.22 Following a 7-month setup phase (July 2021–January 2022), ForWhen was officially ‘launched’ to the public in February 2022 with the opening of a national helpline staffed by clinically trained navigators based in each state and territory of Australia. ForWhen navigators have knowledge of local service systems and pathways within their jurisdictions, and work collaboratively with clients and health service professionals to understand their needs and connect them with appropriate support services. ForWhen is a new programme, and so its impact and effectiveness are currently not well understood. This paper presents the protocol of a programme evaluation aimed at understanding the implementation and outcomes of the ForWhen programme. The evaluation objectives are to: (1) describe the ForWhen service delivery model, (2) evaluate the implementation of the ForWhen programme with a focus on acceptability, adoption, appropriateness, feasibility, fidelity, coverage, cost and sustainability and (3) examine outcomes experienced by clients who access the ForWhen programme, and to identify potential moderators of change across different contexts and participant groups. This evaluation will be conducted over a 3-year period (July 2021–June 2024) and results will be used to make recommendations to guide future ForWhen service delivery, and to inform the development of similar programmes in Australia and internationally. ### Study design During the early design and implementation stages of the ForWhen programme, a programme logic and corresponding outcomes chain was developed by ForWhen consortium members, led by PRC and with representatives from AAPCH and UNSW, and the ForWhen steering committee (including consumer representatives) (figure 1). This model was used to inform the evaluation design, questions and methodology. Specifically, the evaluation protocol seeks to examine the outcomes articulated in the programme logic model, and to assess the degree to which the intervention was implemented as intended. A mixed-methods evaluation protocol was developed using the steps outlined in the NSW Government Programme Evaluation Guidelines23 and the Centre for Disease Control Framework for Programme Evaluation in Public Health.24 The programme evaluation will incorporate three phases that reflect the stages of the programme life-cycle: (1) programme description, (2) implementation evaluation and (3) outcomes evaluation (table 1). ![Figure 1](http://bmjopen.bmj.com/https://bmjopen.bmj.com/content/bmjopen/13/6/e070067/F1.medium.gif) [Figure 1](http://bmjopen.bmj.com/content/13/6/e070067/F1) Figure 1 The ForWhen outcomes chain. PIMH, perinatal and infant mental health. View this table: [Table 1](http://bmjopen.bmj.com/content/13/6/e070067/T1) Table 1 Evaluation questions and planned activities at three phases of the evaluation An early step of the evaluation will be to describe the programme in detail (phase 1), and in doing so to articulate its goals and strategies, its capacity to effect change, and how it fits within the broader PIMH healthcare ecosystem. The programme description will set the frame of reference for subsequent evaluation activities, and facilitate subsequent efforts to connect the various programme components to their effects.24 This phase will focus specifically on documenting the service delivery model of the ForWhen programme and characterising the activities and core competencies involved in navigation. The implementation evaluation (phase 2) will be guided by the work of Proctor *et al*,25 with a focus on key implementation outcome indices including acceptability, adoption, appropriateness, feasibility, fidelity, coverage, cost and sustainability. These implementation outcomes serve as important preconditions for a programme’s success in effecting change in clinical or service outcomes.25 Findings from the implementation evaluation will feed into an analysis of fidelity to the programme model, the identification of facilitators and barriers to successful implementation, and an assessment of cost-effectiveness and longer-term sustainability. The outcomes evaluation (phase 3) will investigate whether the programme is achieving its intended outcomes (eg, improvements in well-being and service utilisation), and, in acknowledgement that health programmes may have varying outcomes across contexts and participants,26 27 effort will also be made to ascertain the groups for, and circumstances under, which positive outcomes are/are not achieved. ### Patient and public involvement The ForWhen steering committee includes consumer representation to provide input into service delivery and intended outcomes to be assessed in this evaluation. Specifically, one of the steering committee members is a consumer with lived experience of perinatal mental illness, who leads consultation more broadly through a number of different consumer groups/networks. A ForWhen consumer and Community Engagement Framework has also been developed to guide programme implementation and the overall evaluation across the three phases. ### Participants Participants in this evaluation will include a range of users and stakeholders involved in the ForWhen programme. User participants will include: clients (ie, expectant or new parents/carers from across all states and territories of Australia) who are facing PIMH challenges and who contact the ForWhen helpline to receive navigation services and support; family/friends (eg, partner, grandparents) who access the ForWhen helpline seeking advice or information in how best to support a parent/carer struggling with PIMH issues; and health professionals who access the ForWhen helpline seeking advice or information in how to find appropriate treatment for someone in their care who is facing PIMH issues, or looking to refer a parent/carer into the programme. Stakeholder participants will include ForWhen navigators and aboriginal liaison workers (clinically trained, ‘place-based’ staff from a range of professional backgrounds, for example, midwifery, nursing, psychology, social work) who staff the national helpline and work one-on-one with users to provide support and navigation services to connect clients with appropriate PIMH treatment; managers who provide direct supervision to navigators; and steering committee members including the national director, PIMH experts, consortium representatives, and project and administrative staff. ### Data collection A mix of quantitative and qualitative data will be used including deidentified routinely collected service data between February 2022 and June 2024, and a range of additional qualitative and quantitative data collected at various points over the 3-year evaluation period (figure 2) in order to achieve the evaluation aims. ![Figure 2](http://bmjopen.bmj.com/https://bmjopen.bmj.com/content/bmjopen/13/6/e070067/F2.medium.gif) [Figure 2](http://bmjopen.bmj.com/content/13/6/e070067/F2) Figure 2 Data collection time points. ### Qualitative data collection #### Participant observation To describe the programme and its implementation, a researcher will conduct participant observation at regular committee meetings during the early design and implementation phases of the programme, over a period of approximately 6 months (figure 2). Meeting attendees will include ForWhen stakeholders representing different roles (eg, steering committee members, managers, navigators), organisations and jurisdictions. The researcher will record field notes during these meetings with a focus on documenting and describing the ForWhen service delivery model, governance structure and staff roles, barriers to implementation and steps taken to address these barriers. #### Semistructured interviews Semistructured interviews will be conducted with stakeholders (navigators, managers, steering committee members) and users (clients, family/friends, health professionals) of the programme at various points throughout its implementation (figure 2). Interviews with ForWhen navigators in the first year of the programme will explore the service delivery model, core competencies and activities involved in navigation, and barriers and facilitators to early implementation of the programme on the ground. Interviews with other ForWhen stakeholders (including managers and steering committee members) in the first year of the programme will explore the governance structure, and barriers and facilitators to early implementation from a management and governance perspective. Follow-up interviews with ForWhen navigators and stakeholders in the third year of the programme will explore programme evolution, and stakeholder perceptions on longer-term feasibility and effectiveness of the programme. Interviews with users (including clients, family/friends or health professionals) in the second year of the programme will explore reasons for accessing and satisfaction with the programme, perceived outcomes and usefulness, and barriers and facilitators to positive outcomes. ### Quantitative data collection #### Review of routinely collected service data As a routine part of the ForWhen programme, data relating to individual clients and service provision is collected by navigators and managed via a Customer Relationship Management (CRM) database. At programme entry (baseline), navigators administer the K10 as part of routine mental health assessment, and collect client data including demographic information and identified psychosocial risk factors during an intake interview (figure 3 and table 2). Throughout each client’s engagement with the programme, individual service provision data including number and mode of contacts with the navigator, services provided by the navigator (eg, psychoeducation) and the number and types of referrals made, are routinely recorded by navigators in the CRM database (table 2). In the final year of the programme, retrospective analysis of this routinely collected service data will be conducted in order to characterise the clients (eg, demographics, K10 scores and psychosocial risks) and service provision of the ForWhen programme, evaluate changes in client psychological distress from ForWhen programme entry to follow-up, and identify potential moderators of change. ![Figure 3](http://bmjopen.bmj.com/https://bmjopen.bmj.com/content/bmjopen/13/6/e070067/F3.medium.gif) [Figure 3](http://bmjopen.bmj.com/content/13/6/e070067/F3) Figure 3 Quantitative data collection time points during client journey. Notes. *Administered to all clients and automatically collected by the for when client database; †Administered by the search team to a sub-set of clients during 6-month snaoshot study period, View this table: [Table 2](http://bmjopen.bmj.com/content/13/6/e070067/T2) Table 2 Quantitative data collection time points and information collected/measures administered #### Snapshot study During a 6-month period in the second year of the programme, the research team will recruit ForWhen clients (parents/carers) to a ‘snapshot study’ to evaluate the programme’s impact on additional parent and infant outcomes. All clients who access ForWhen during this study period will be eligible to participate, and those who opt-in will be asked to complete a series of validated questionnaires at baseline (within 1 week of accessing the programme) and follow-up (10–12 weeks after programme exit) either online or over the phone. Participants will also provide consent for this data to be linked to their client information held in the CRM database. Key variables of interest and accompanying questionnaires to be included in the snapshot survey are shown in table 2. #### Economic evaluation An exploratory economic evaluation will estimate the potential cost effectiveness and return-on-investment from both a health and societal perspective.28 A within-trial analysis will estimate the costs of delivering ForWhen, including: (1) navigator salary (and oncosts), training and pro-rata supervision and (2) associated direct costs, such as office space, equipment, technology. The utilisation of referral services will be tracked and costed using MBS fee schedules (including out-of-pocket costs, where relevant). The main study outcome of K10 will then be converted to health utilities as the measure of effectiveness, with before and after measures (6 months). A literature review will be conducted to generate a plausible counterfactual regarding services utilisation and K10 scores in the absence of ForWhen.29 Economic modelling will then project longer-term impacts of ForWhen and the counterfactual on sustained changes in K10 scores and ongoing service use (health and social services), and productivity impacts where K10 scores are a validated predictor.30 31 A probability sensitivity analysis and value of information analysis will make the economic case to invest in long-term follow-up data to replace model assumptions with observed data.32 Key economic metrics of value will be the incremental cost-effectiveness ratio and a (pragmatic) social return on investment, using all costs and outcomes data. Finally, a budget impact analysis will the estimate the investment costs if ForWhen was implemented nationally. ### Data analysis Qualitative data including field notes and interview transcripts will be stored securely as electronic documents on a password protected computer. Interviews will be audio recorded and transcribed verbatim. Qualitative data will be analysed using framework analysis, a thematic analytical method that involves data familiarisation, coding, developing a framework, indexing, charting and interpretation.33 Coding and analysis will be conducted using NVivo V.12 software (QSR International). Quantitative data will be collected from the programme’s CRM database, exit surveys and snapshot study questionnaires, and stored in a password protected database. Data will be analysed using appropriate descriptive and inferential statistics in SPSS, version 27 Statistics (IBM). For each of the key outcome measures (psychological distress (K10), parenting self-efficacy (MaaP-SF), personal well-being (PWI), help-seeking behaviour (General Help-Seeking Questionnaire), self-compassion and self-care (PRC questions) and mother-to-infant bonding), sensitivity analyses will be conducted prior to undertaking the main quantitative analysis (eg, to test the influence of outliers, missing data, protocol deviations). A linear mixed models repeated measures design will then be used to examine changes on these key outcome variables from programme entry to follow-up. The clinical significance of differences on study variables (from baseline to follow-up) will be assessed using Cohen’s d with effect sizes evaluated using Cohen’s34 guidelines. Power calculations suggest that with power of 0.80 and alpha 0.05, a sample size of N=90 would enable detection of small-to-moderate effect size changes on key variables (eg, depression symptoms assessed using the K10 and parenting self-efficacy assessed using the MaaP-SF). Based on early service utilisation data, we expect an anticipated sample size for the snapshot study of approximately n=200–250, indicating that the sample will be adequately powered. With the larger sample, we will also be able to conduct secondary analyses to explore factors that impact effectiveness. Several variables will be tested as potential outcome moderators: depression symptom severity on intake, place of residence (eg, metropolitan vs regional/remote, and callers living in the different states and territories of Australia), intervention dosage (eg, number of contacts with ForWhen navigator, duration from entry to exit, services provided). Researchers conducting the evaluation will have access to deidentified routinely collected service data, which will be used in aggregate analyses (no individual cases will be examined in isolation). For all additional data collection, participants will provide informed, written consent. Names and identifying information will be removed from qualitative data prior to publication, and quantitative data will only be used in aggregate analyses, to protect participant anonymity. This research was approved by South Western Sydney Local Health District Human Research Ethics Committee (2021/ETH11611) and has been registered on the Australian New Zealand Clinical Trials Registry (ACTRN12622001443785). This evaluation will be an integral part of the implementation of the ForWhen programme. Evaluation findings will be presented regularly to the programme steering committee and national director, with a view to improving the programme throughout the implementation period and translating findings into practice. Results will also be disseminated at conferences, in scientific journals and in a final evaluation report. ## Discussion This protocol outlines the study design, methods and analyses that will be used to conduct a comprehensive evaluation of the ForWhen navigation programme. Navigation models have been adopted in a range of healthcare including PIMH,35 but their impact on clinical outcomes and evaluation of implementation including barriers and enablers in the engagement with PIMH services is currently not well understood. The findings of this evaluation will advance understanding on the potential of navigation programmes such as ForWhen to enhance service connection and treatment for PIMH on a national scale, and help to inform sustainable and effective programme design in future. The planned evaluation does, however, have limitations. The most notable limitation is the ‘open trial’ study design to be utilised for the outcomes evaluation. A randomised controlled study design is not feasible given the programme objective for system-wide changes, and the observational nature of the evaluation component. Given that the ForWhen navigation programme is designed to connect families with needed care and support, a challenge will be to disentangle the impact of the navigation intervention from the benefits conveyed by connected services. To mitigate this, we plan to administer follow-up measures relatively soon after intervention exposure (10–12 weeks). We also plan to explore potential moderators of change (eg, intensity and type of navigation services received). As the primary goal of navigation is to connect clients to appropriate services, it will also be important to look beyond clinical outcomes and examine participants’ engagement with mental health treatment at follow-up, and their satisfaction with both the navigation and referred services. This evaluation will make important contributions to the literature on navigation service models in improving PIMH care. First, it will be used to develop a detailed model of clinical navigation work and identify the core competencies and desired skillset of navigators, which may help inform other programmes adopting similar models. Second, it will identify barriers and facilitators in successful navigation programme implementation on both local and national scales. Third, it will examine the impact of a national navigation programme on clinical outcomes and health service utilisation among those facing PIMH issues in Australia. Fourth, the national dataset will provide an opportunity to identify patterns of need and service gaps among different demographic groups and jurisdictions throughout Australia, which will be used to inform future funding allocations and service delivery planning. And fifth, the evaluation will assess the cost-effectiveness and longer-term sustainability of a national navigation programme in improving PIMH health outcomes in Australia. ## Ethics statements ### Patient consent for publication Not applicable. ## Footnotes * Contributors JK and VE conceived of the project and drafted the initial protocol. JK and SAH refined the study design and protocol. JK, SAH and KDL drafted the published protocol paper, and all authors provided feedback and approved the final version. * Funding This research was funded by an Australian Government Perinatal Mental Health Programme—Emerging Priorities Grant (GO4213). * Competing interests JK works in a cofunded academic position with UNSW and Karitane (ForWhen lead agency). * Patient and public involvement Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details. * Provenance and peer review Not commissioned; externally peer reviewed. [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/) This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/). ## References 1. Gavin NI, Gaynes BN, Lohr KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106(5 Pt 1):1071–83. [doi:10.1097/01.AOG.0000183597.31630.db](http://dx.doi.org/10.1097/01.AOG.0000183597.31630.db) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1097/01.AOG.0000183597.31630.db&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=16260528&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) [Web of Science](http://bmjopen.bmj.com/lookup/external-ref?access_num=000233018800026&link_type=ISI) 2. Leach LS, Poyser C, Fairweather‐schmidt K. Maternal perinatal anxiety: A review of prevalence and correlates. Clinical Psychologist 2017;21:4–19. [doi:10.1111/cp.12058](http://dx.doi.org/10.1111/cp.12058) 3. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. The Lancet 2014;384:1800–19. [doi:10.1016/S0140-6736(14)61277-0](http://dx.doi.org/10.1016/S0140-6736(14)61277-0) 4. Ruffell B, Smith DM, Wittkowski A. The experiences of male partners of women with postnatal mental health problems: a systematic review and thematic synthesis. J Child Fam Stud 2019;28:2772–90. [doi:10.1007/s10826-019-01496-4](http://dx.doi.org/10.1007/s10826-019-01496-4) 5. Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry 2020;19:313–27. [doi:10.1002/wps.20769](http://dx.doi.org/10.1002/wps.20769) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1002/wps.20769&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 6. Austin M-P, Reilly N, Sullivan E. The need to evaluate public health reforms: Australian perinatal mental health initiatives. Aust N Z J Public Health 2012;36:208–11. [doi:10.1111/j.1753-6405.2012.00851.x](http://dx.doi.org/10.1111/j.1753-6405.2012.00851.x) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1111/j.1753-6405.2012.00851.x&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=22672024&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 7. Cox EQ, Sowa NA, Meltzer-Brody SE, et al. The perinatal depression treatment Cascade: baby steps toward improving outcomes. J Clin Psychiatry 2016;77:1189–200. [doi:10.4088/JCP.15r10174](http://dx.doi.org/10.4088/JCP.15r10174) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.4088/JCP.15r10174&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=27780317&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 8. Highet NJ, Bilbao F. The Western perinatal emotional health pilot program: final report; 2015. 9. Reilly N, Harris S, Loxton D, et al. Disparities in reported Psychosocial assessment across public and private maternity settings: a national survey of women in Australia. BMC Public Health 2013;13:632. [doi:10.1186/1471-2458-13-632](http://dx.doi.org/10.1186/1471-2458-13-632) 10. Australian Government Productivity Commission. Mental health inquiry Reportno.95. AGPC. Canberra, ACT, Australia; 2020. 11. Schmied V, Langdon R, Matthey S, et al. Antenatal Psychosocial risk status and Australian women’s use of primary care and specialist mental health services in the year after birth: a prospective study. BMC Womens Health 2016;16:69. [doi:10.1186/s12905-016-0344-0](http://dx.doi.org/10.1186/s12905-016-0344-0) 12. Austin MPN. Highet, and Expert Working Group, Mental health care in the perinatal period: Australian clinical practice guideline. Melbourne, Australia: Centre of Perinatal Excellence, 2017. 13. Brown S, Sprague C. Health care providers’ perceptions of barriers to perinatal mental Healthcare in South Africa. BMC Public Health 2021;21. [doi:10.1186/s12889-021-11954-8](http://dx.doi.org/10.1186/s12889-021-11954-8) 14. Byatt N, Biebel K, Lundquist RS, et al. Patient, provider, and system-level barriers and Facilitators to addressing perinatal depression. Journal of Reproductive and Infant Psychology 2012;30:436–49. [doi:10.1080/02646838.2012.743000](http://dx.doi.org/10.1080/02646838.2012.743000) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1080/02646838.2012.743000&link_type=DOI) 15. Knesek G, Hemphill T. Mental health navigation–a model. Health Promot Int 2020;35:151–9. [doi:10.1093/heapro/day109](http://dx.doi.org/10.1093/heapro/day109) 16. Kelly KJ, Doucet S, Luke A. Exploring the roles, functions, and background of patient navigators and case managers: A Scoping review. Int J Nurs Stud 2019;98:27–47. [doi:10.1016/j.ijnurstu.2019.05.016](http://dx.doi.org/10.1016/j.ijnurstu.2019.05.016) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1016/j.ijnurstu.2019.05.016&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 17. Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer 2011;117(15 Suppl):3539–42. [doi:10.1002/cncr.26262](http://dx.doi.org/10.1002/cncr.26262) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=21780088&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) [Web of Science](http://bmjopen.bmj.com/lookup/external-ref?access_num=000293104000002&link_type=ISI) 18. Fallin-Bennett A, Rademacher K, Dye H, et al. Perinatal navigator approach to smoking cessation for women with prevalent opioid dependence. West J Nurs Res 2019;41:1103–20. [doi:10.1177/0193945918825381](http://dx.doi.org/10.1177/0193945918825381) 19. Silverstein M, Diaz-Linhart Y, Grote N, et al. Patient navigation for depressed mothers in head start: A pilot study of intervention mechanism. J Community Psychol 2017;45:564–70. [doi:10.1002/jcop.21861](http://dx.doi.org/10.1002/jcop.21861) 20. Yee LM, Martinez NG, Nguyen AT, et al. Using a patient navigator to improve postpartum care in an urban women’s health clinic. Obstet Gynecol 2017;129:925–33. [doi:10.1097/AOG.0000000000001977](http://dx.doi.org/10.1097/AOG.0000000000001977) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 21. Diaz-Linhart Y, Silverstein M, Grote N, et al. Patient navigation for mothers with depression who have children in head start: A pilot study. Soc Work Public Health 2016;31:504–10. [doi:10.1080/19371918.2016.1160341](http://dx.doi.org/10.1080/19371918.2016.1160341) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=27195704&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 22. Karitane. Proposal for pre-budget submission for Commonwealth funding 2021-2022; 2021. 23. NSW Government,. NSW government program evaluation guidelines; 2016. 24. Centers for Disease Control and Prevention. [CDC]. In: Framework for Program Evaluation in Public Health. 1999. 25. Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health 2011;38:65–76. [doi:10.1007/s10488-010-0319-7](http://dx.doi.org/10.1007/s10488-010-0319-7) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1007/s10488-010-0319-7&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=20957426&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 26. Pawson R, Tilley N. Realistic evaluation. Sage, 1997. 27. Wand T, White K, Patching J. Contemporary mental health program implementation and evaluation. Issues Ment Health Nurs 2010;31:716–22. [doi:10.3109/01612840.2010.503008](http://dx.doi.org/10.3109/01612840.2010.503008) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=20936893&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 28. Drummond MF, et al. Methods for the economic evaluation of health care programmes. Oxford university press, 2015. 29. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet 2014;384:1800–19. [doi:10.1016/S0140-6736(14)61277-0](http://dx.doi.org/10.1016/S0140-6736(14)61277-0) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1016/S0140-6736(14)61277-0&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=25455250&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) [Web of Science](http://bmjopen.bmj.com/lookup/external-ref?access_num=000345116400031&link_type=ISI) 30. Lawson KD, Occhipinti J-A, Freebairn L, et al. A dynamic approach to economic priority setting to invest in youth mental health and guide local implementation: economic protocol for eight system Dynamics policy models. Front Psychiatry 2022;13:13. [doi:10.3389/fpsyt.2022.835201](http://dx.doi.org/10.3389/fpsyt.2022.835201) 31. Australian Government. Productivity Commission, mental health inquiry report; 2020. 32. Briggs AH, Weinstein MC, Fenwick EAL, et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working Group–6. Med Decis Making 2012;32:722–32. [doi:10.1177/0272989X12458348](http://dx.doi.org/10.1177/0272989X12458348) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1177/0272989X12458348&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=22990087&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) [Web of Science](http://bmjopen.bmj.com/lookup/external-ref?access_num=000310163100010&link_type=ISI) 33. Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 2013;13:117. [doi:10.1186/1471-2288-13-117](http://dx.doi.org/10.1186/1471-2288-13-117) 34. Cohen J. Statistical power analysis for the behavioral sciences. New York: Routledge, 1988. 35. DiSanza CB, Geller PA, Bonacquisti A, et al. A stepped care model of patient navigation to enhance engagement with perinatal mental health care. Health Equity 2020;4:484–8. [doi:10.1089/heq.2020.0077](http://dx.doi.org/10.1089/heq.2020.0077) 36. Kessler RC, Barker PR, Colpe LJ, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60:184. [doi:10.1001/archpsyc.60.2.184](http://dx.doi.org/10.1001/archpsyc.60.2.184) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1001/archpsyc.60.2.184&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=12578436&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) [Web of Science](http://bmjopen.bmj.com/lookup/external-ref?access_num=000180873200009&link_type=ISI) 37. Matthews J, Millward C, Hayes L, et al. Development and validation of a short-form parenting self-efficacy scale: me as a parent scale (Maaps-SF). J Child Fam Stud 2022;31:2292–302. [doi:10.1007/s10826-022-02327-9](http://dx.doi.org/10.1007/s10826-022-02327-9) 38. International Wellbeing Group. Personal Wellbeing Index5th Edition. Melbourne: Australian Centre on Quality of Life, Deakin University, 2013. 39. Wilson CJ, et al. Measuring help seeking intentions: properties of the general help seeking questionnaire; 2005. 40. Taylor A, Atkins R, Kumar R, et al. A new mother-to-infant bonding scale: links with early maternal mood. Arch Womens Ment Health 2005;8:45–51. [doi:10.1007/s00737-005-0074-z](http://dx.doi.org/10.1007/s00737-005-0074-z) 41. Fishman KN, Levitt AJ, Markoulakis R, et al. Satisfaction with mental health navigation services: piloting an evaluation with a new scale. Community Ment Health J 2018;54:521–32. [doi:10.1007/s10597-017-0201-0](http://dx.doi.org/10.1007/s10597-017-0201-0) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) 42. Mercer SW, Maxwell M, Heaney D, et al. The consultation and relational empathy (CARE) measure: development and preliminary validation and reliability of an empathy-based consultation process measure. Fam Pract 2004;21:699–705. [doi:10.1093/fampra/cmh621](http://dx.doi.org/10.1093/fampra/cmh621) [CrossRef](http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1093/fampra/cmh621&link_type=DOI) [PubMed](http://bmjopen.bmj.com/lookup/external-ref?access_num=15528286&link_type=MED&atom=%2Fbmjopen%2F13%2F6%2Fe070067.atom) [Web of Science](http://bmjopen.bmj.com/lookup/external-ref?access_num=000225531000018&link_type=ISI)